Skip Navigation


Radiation Protection Dosimetry Advance Access originally published online on July 12, 2007
Radiation Protection Dosimetry 2008 128(3):336-342; doi:10.1093/rpd/ncm363
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
128/3/336    most recent
ncm363v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Wang, B.
Right arrow Articles by Xu, X. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, B.
Right arrow Articles by Xu, X. G.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2007. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Measurements of non-target organ doses using MOSFET dosemeters for selected IMRT and 3D CRT radiation treatment procedures

Brian Wang1 and X. George Xu2,*

1 Radiation Oncology, Huntsman Cancer Hospital, University of Utah, Salt Lake City, UT 84112, USA
2 Nuclear Engineering and Engineering Physics Program, Room 1-11, NES Building, Rensselaer Polytechnic Institute, Troy, NY 12180, USA

* Corresponding author: xug2{at}rpi.edu

Received December 18, 2006, amended April 2, 2007, accepted June 13, 2007

Many expressed concerns about the potential increase in second cancer risk from the widespread shift to intensity-modulated radiation therapy (IMRT) techniques from traditional 3-D conformal radiation treatment (3D CRT). This paper describes the study on in-phantom measurements of radiation doses in organ sites away from the primary tumour target. The measurements involved a RANDO® phantom and Metal Oxide Semiconductor Field Effect Transistor dosemeters for selected 3D CRT and IMRT treatment plans. Three different treatment plans, 4-field 3D CRT, 6-field 3D CRT and 7-field IMRT for the prostate, were considered in this study. Steps to reconstruct organ doses from directly measured data were also presented. The dosemeter readings showed that the doses decrease as the distances increase for all treatment plans. At 40 cm from the prostate target, doses were <1% of the therapeutic dose. At this location, however, the IMRT plan resulted in an absorbed dose from photons, that is a factor of 3–5 higher than the 3D CRT treatment plans. This increase on absorbed dose is due to the increased exposure time for delivering the IMRT plan. The total monitor unit (MU) was 2850 for the IMRT case, while the MU was 1308 and 1260 for 6-field and 4-field 3D CRT cases, respectively. Findings from this case study involving the prostate treatments agree with those from previous studies that IMRT indeed delivers higher photon doses to locations that are away from the primary target.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.